Intermittent intravaginal antibiotic treatment of bacterial vaginosis in HIV-uninfected and -infected women: A randomized clinical trial

PLoS Clinical Trials

Volumn 2, Issue 2, 2007, Pages

  Taha, Taha E ^a   Kumwenda, Newton I ^a   Kafulafula, George ^b   Makanani, Bonus ^b   Nikhoma, Chiwawa ^c   Chen, Shu ^a   Tsui, Amy ^a   Hoover, Donald R ^d  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF MALAWI   (Malawi)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; METRONIDAZOLE; PLACEBO;

ADULT; ARTICLE; CANDIDIASIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INTERMITTENT THERAPY; DRUG SAFETY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; INFECTION RATE; INFECTION RISK; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALAWI; MULTICENTER STUDY; MULTIVARIATE ANALYSIS OF COVARIANCE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PHASE 3 CLINICAL TRIAL; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; RECURRENT INFECTION; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; VAGINA FLORA; VAGINITIS; VULVA DISEASE;

EID: 34249785687     PISSN: None     EISSN: 15555887     Source Type: Journal    
DOI: 10.1371/journal.pctr.0020010     Document Type: Article

References (30)

1. Sewankambo N, Gray RH, Wawer MJ, Paxton L, McNaim D, et al. (1997) HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet 350: 546-550.
2. Govender L, Hoosen AA, Moodely J, Moodely P, Sturm AW (1996) Bacterial vaginosis and associated infections in pregnancy. Int J Gynecol Obstet 55: 23-28.
3. Hillier S, Holmes KK. (1999) Bacterial vaginosis. In: Sexually Transmitted Diseases, 3rd Edition. Homes KK, Sparling PF, Mardh P-A, Lemon SM, Stamm WE, et al. editors. New York: McGraw-Hill. pp. 563-586.
4. Centers for Disease Control (1998) 1998 guidelines for treatment of sexually transmitted diseases. MMWR 47 No. RR-1: 7-74.
5. Paavonen J (1983) Physiology and ecology of the vagina. Scand J Infect Dis 40: 31-35.
6. Hillier SL (1993) Diagnostic microbiology of bacterial vaginosis. Am J Obstet Gynecol 169: 455-459.
7. Hillier SL, Krohn MA, Nugent RP, Gibbs RSthe Vaginal Infections and Prematurity Study Group (1992) Characteristics of three vaginal flora patterns assessed by Gram stain among pregnant women. Am J Obstet Gynecol 166: 938-944.
8. Holmes KK, Chen KCS, Lipinski CM, Eschenbach DA (1985) Vaginal redox potential inbacterial vaginosis (nonspecific vaginitis). J Infect Dis 152: 379-382.
9. Hanson JM, McGregor JA, Hillier SL, Eschenbach DA, Kreutner AK, et al. (2000) Metronidazole for bacterial vaginosis. A comparison of vaginal gel vs. oral therapy. J Reprod Med 45: 889-896.
10. Taha TE, Hoover DR, Dallabetta GA, Kumwenda NI, Mtimavalye LA, et al. (1998) Bacterial vaginosis and disturbances of vaginal flora: Association with increased acquisition of HIV. AIDS 12: 1699-1706.
11. Taha TE, Gray RH, Kumwenda NI, Hoover DR, Mtimavalye LA, et al. (1999) HIV infection and disturbances of vaginal flora during pregnancy. J Acquir Immune Defic Syn Hum Retrovirol 20: 52-59.
12. 3M Pharmaceuticals (1997) MetroGel-Vaginal [package insert]. Available: http://multimedia.mmm.com/mws/mediawebserver.dyn? 6666660Zjcf6lVs6EVs66Sy&9COrrrrQ-. Accessed 31 October 2006.
13. Nugent RP, Krohn MA, Hillier SL (1991) Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation. J Clin Microbiol 29: 297-301.
14. Kumwenda N, Hoffman I, Chirenje M, Kelly C, Coletti A, et al. (2006) HIV incidence among women of reproductive age in Malawi and Zimbabwe (HIVNET/ HPTN 016A). Sex Transm Dis 33: 646-651.
15. Division of AIDS, NIAID/NIH/DHHS (2003) Code of Federal Regulations ICH Guidelines. Philadelphia: Clinical Research Resources. Available: http://www.clinicalresearchresources.com. Accessed 1 Aug 2006.
16. Wawer MJ, Sewankambo NK, Serwada D, Quinn TC, Paxton LA, et al. (1999) Control of sexually transmitted diseases for AIDS prevention in Uganda: A randomized community trial. Lancet 353: 525-535.
17. Sobel J (2005) What is new in bacterial vaginosis and trichomoniasis? Infect Dis Clin N Am 19: 387-406.
18. Sobel JD (1997) Vaginitis. N Engl J Med 337: 1896-1903.
19. Hillier SL, Lipinski C, Briselden AM, Eschenbach DA (1993) Efficacy of intravaginal 0.75% metronidazole gel for the treatment of bacterial vaginosis. Obstet Gynecol 81: 963-967.
20. Livengood CH, Soper DE, Sheehan KL, Fenner DE, Martens MG, et al. (1999) Comparison of once-daily and twice-daily dosing of 0.75% metronidazole gel in the treatment of bacterial vaginosis. Sex Trasm Dis 26: 137-142.
21. van de Wijgert J, Fullem A, Kelly C, Mehendale S, Rugpao S, et al. (2001) Phase I trial of the topical microbicide BufferGel: Safety results from four international sites. J Acquir Immune Defic Syndr 26: 21-27.
22. Ness RB, Hillier SL, Richter HE, Soper DE, Stamm C, et al. (2002) Douching in relation to bacterial vaginosis, lactobacilli, and facultative bacteria in the vagina. Obstet Gynecol 100: 765-772.
23. van de Wijgert J, Jones H (2006) Challenges in microbicide trial design and implementation. Stud Fam Plann 37: 123-129.
24. Gray RH, Wawer MJ, Serwadda D, Sewankambo N, Li S, et al. (1998) Population-based study of fertility in women with HIV-1 infection in Uganda. Lancet 351: 98-103.
25. Cunningham FE, Kraus DM, Brubaker L, Fischer JH (1994) Pharmacokinetics of intravaginal metronidazole gel. J Clin Pharmacol 34: 1060-1065.
26. Dallabetta GA, Miotti PG, Chiphangwi JD, Liomba G, Saah AJ (1995) Traditional vaginal agents: Prevalence of use and associations with HIV-1 infection in Malawian women. AIDS 9: 293-297.
27. Taha TE, Dallabetta GA, Hoover DR, Chiphangwi JD, Mtimavalye LAR, et al. (1998) Trends of HIV-1 and sexually transmitted diseases among pregnant and postpartum women in urban Malawi. AIDS 12: 197-203.
28. Larsson PG, Bergstrom M, Forsum U, Jacobsson B, Strnd A, et al. (2005) Bacterial vaginosis. Transmission, role in genital tract infection and pregnancy outcome: An enigma. Review article III. APMIS 113: 233-245.
29. Joesoef MR, Schmid GP, Hillier SL (1999) Bacterial vaginosis: Review of treatment options and potential clinical indications for therapy. Clin Infect Dis 28: S57-S65.
30. Sobel JD, Ferris D, Schwebke J, Nyirjesy P, Wiesenfeld HC, et al. (2006) Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. Am J Obstet Gynecol 194: 1283-1289.